Investigating propofol-sufentanil interaction using clinical endpoints and processed electroencephalography: a...

Area of Science:

• Anesthesiology
• Pharmacology
• Neuroscience

Background:

• Target-controlled infusion (TCI) of propofol and sufentanil is increasingly utilized in anesthesia.
• Drug interaction modeling is crucial for optimizing anesthetic drug concentrations.
• Processed electroencephalography (EEG) and clinical endpoints aid in determining adequate anesthesia levels.

Purpose of the Study:

• To investigate the synergistic interaction between sufentanil and propofol.
• To quantify the effect of sufentanil on the propofol concentration required for loss of responsiveness.
• To assess the impact of sufentanil on EEG-based depth of hypnosis monitoring.

Main Methods:

• Sixty patients were randomized into three groups receiving different sufentanil concentrations (0, 0.25, or 0.5 ng/mL).
• Propofol was administered using TCI, with concentrations increased stepwise.
• Processed EEG (Bispectral Index, Narcotrend Index) and auditory evoked potentials (cAAI) were recorded simultaneously.
• Probit and nonlinear regression analyses were used to model drug interactions.

Main Results:

• Sufentanil demonstrated a dose-dependent synergistic effect, significantly reducing the propofol concentration needed for loss of responsiveness and response to noxious stimulation.
• Non-linear regression analysis confirmed sufentanil's synergistic impact on propofol's EC50 for Bispectral Index, Narcotrend Index, and cAAI.
• The observed synergy indicates that co-administration of sufentanil allows for lower propofol doses while maintaining anesthetic depth.

Conclusions:

• Sufentanil exerts a synergistic effect on the hypnotic properties of propofol, as evidenced by clinical measures and EEG.
• This synergy allows for dose reduction of propofol when combined with sufentanil, potentially improving patient outcomes.
• The findings are applicable to depth of hypnosis monitoring using Bispectral Index, Narcotrend Index, and cAAI.